1. Allen, B.J. Boron neutron capture therapy-a research program for glioblastoma and melanoma. Aust. Phys. Eng. Sci. Med. 6, 184–186 (1983).
2. Allen, B.J. In vitro and in vivo studies in boron neutron capture therapy of malignant melanoma. Proc. First Int. Symp. Neutron Capture Therapy, MIT, Boston, Oct. 1983. Fairchild, R.G.; Brownell G.L., eds., BNL51730, 341–354.
3. Tamat, S.R.; Moore, D.E.; Patwardhan, A.; Hersey, P. Boronated monoclonal antibody 225.28S for potential use in neutron capture therapy of malignant melanoma. Pigm. Cell Res. 2, 278–280 (1989).
4. Wilson, J.G. Synthetic approach to a decarboranyl thiouracil. Pigm. Cell Res. 2, 297–303 (1989).
5. Wilson, J.G. Carborane compounds for neutron capture therapy ofmalignant melanoma. In: Progress in Neutron Capture Therapy for Cancer. Allen, B.J.; Moore, D.E.; Harrington, B.V., eds., Plenum Press, New York, 227–230 (1992).